Klinicki bolnicki centar Split
Split, Croatia
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Pfizer492 enrolled273 locationsNCT06152575
Recruiting
Not Applicable
Feasibility Study of the FARAFLEX Mapping and PFA System
Atrial FibrillationPersistent Atrial FibrillationParoxysmal AF
Boston Scientific Corporation250 enrolled4 locationsNCT06510556